Profil
Yu Hong Geng served as a Member-Supervisory Board at BIOTON SA. Later, from 2014 to 2021, Geng worked as a Vice President at Shanghai United Cell Biotechnology Co. Ltd.
Geng holds a doctorate degree from the University of Hong Kong, which was conferred in 2002.
Additionally, Geng holds a graduate degree from Fudan University, which was conferred in 1996.
Anciens postes connus de Yu Hong Geng
| Sociétés | Poste | Fin |
|---|---|---|
Shanghai United Cell Biotechnology Co. Ltd.
 Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of United Laboratories, Inc., Shanghai United Cell Biotechnology Co. Ltd. is an industrialized base that integrates the research and development, manufacturing, and sales of genetic reorganization biological products and vaccines. The company is based in Shanghai, China. The Chinese company has always adhered to the principle of developing high-quality drugs and vaccine products through innovation to better serve society and benefit humanity. The company's products include injection reorganization typa peptide reorganization B sub-sub-unit/bacterial cholera vaccine, injection of employment growth hormone in employment hormone. | Directeur Technique/Scientifique/R&D | 01/07/2014 |
| BIOTON S.A. | Directeur/Membre du Conseil | - |
Formation de Yu Hong Geng
| University of Hong Kong | Doctorate Degree |
| Fudan University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOTON S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of United Laboratories, Inc., Shanghai United Cell Biotechnology Co. Ltd. is an industrialized base that integrates the research and development, manufacturing, and sales of genetic reorganization biological products and vaccines. The company is based in Shanghai, China. The Chinese company has always adhered to the principle of developing high-quality drugs and vaccine products through innovation to better serve society and benefit humanity. The company's products include injection reorganization typa peptide reorganization B sub-sub-unit/bacterial cholera vaccine, injection of employment growth hormone in employment hormone. | Health Technology |
